CD4 and infection: Based on these findings, higher infusion of TIL cells and the percentage of CD8+ TIL, less infusion of CD8+PD1+ TIL and CD4+FoxP3+ TIL, and infection with HPV and fever are potential factors predicting the response to TILs and anti-PD1 combination therapy.